Td Private Client Wealth LLC Denali Therapeutics Inc. Transaction History
Td Private Client Wealth LLC
- $4.44 Trillion
- Q3 2025
A detailed history of Td Private Client Wealth LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 71 shares of DNLI stock, worth $1,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71Holding current value
$1,090% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
252Shares Held
134MCall Options Held
148KPut Options Held
15.4K-
Black Rock Inc. New York, NY13.2MShares$202 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$181 Million0.0% of portfolio
-
Baillie Gifford & CO11.6MShares$178 Million0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.58MShares$101 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.26MShares$96.2 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.06B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...